FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:857-859 February 26, 2004 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Gladwin, M. T. PubMed Citation

Sickle cell disease was first described in 1910 by Herrick and Irons. The irregularly shaped blood cells observed by Irons were those of Walter Clement Noel, a dental student with symptoms that included joint pain and shortness of breath. After graduation, Dr. Noel returned to his native Grenada, where he died suddenly at 32 years of age. Although the cause of death was recorded as pneumonia, his death was most likely the result of sudden, undetected pulmonary hypertension.

Today, we know that pulmonary hypertension and chronic lung disease are two of the most common causes of death among patients with . . . [Full Text of this Article]

Source Information

From the Department of Hematology–Oncology, Northern California Sickle Cell Center, Children's Hospital and Research Center at Oakland.

This article has been cited by other articles:

• Gladwin, M. T., Vichinsky, E. (2008). Pulmonary Complications of Sickle Cell Disease. NEJM 359: 2254-2265 [Full Text]  
• De Franceschi, L., Platt, O. S., Malpeli, G., Janin, A., Scarpa, A., Leboeuf, C., Beuzard, Y., Payen, E., Brugnara, C. (2008). Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice. FASEB J. 22: 1849-1860 [Abstract] [Full Text]  
• Gladwin, M. T., Kato, G. J. (2008). Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!. haematol 93: 1-3 [Full Text]  
• Villagra, J., Shiva, S., Hunter, L. A., Machado, R. F., Gladwin, M. T., Kato, G. J. (2007). Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110: 2166-2172 [Abstract] [Full Text]  
• Anthi, A., Machado, R. F., Jison, M. L., Taveira-DaSilva, A. M., Rubin, L. J., Hunter, L., Hunter, C. J., Coles, W., Nichols, J., Avila, N. A., Sachdev, V., Chen, C. C., Gladwin, M. T. (2007). Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 175: 1272-1279 [Abstract] [Full Text]  
• Aessopos, A., Kati, M., Farmakis, D. (2007). Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. haematol 92: 658-665 [Abstract] [Full Text]  
• Vercellotti, G. M. (2007). The "NO" tipping point. Blood 109: 2675-2675 [Full Text]  
• Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., Noguchi, C. T., Gladwin, M. T. (2007). Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109: 3088-3098 [Abstract] [Full Text]  
• Raghavachari, N., Xu, X., Harris, A., Villagra, J., Logun, C., Barb, J., Solomon, M. A., Suffredini, A. F., Danner, R. L., Kato, G., Munson, P. J., Morris, S. M. Jr, Gladwin, M. T. (2007). Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease. Circulation 115: 1551-1562 [Abstract] [Full Text]  
• Sachdev, V., Machado, R. F., Shizukuda, Y., Rao, Y. N., Sidenko, S., Ernst, I., St. Peter, M., Coles, W. A., Rosing, D. R., Blackwelder, W. C., Castro, O., Kato, G. J., Gladwin, M. T. (2007). Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease. J Am Coll Cardiol 49: 472-479 [Abstract] [Full Text]  
• Medoff, B. D., Shepard, J.-A. O., Smith, R. N., Kratz, A. (2005). Case 17-2005 - A 22-Year-Old Woman with Back and Leg Pain and Respiratory Failure. NEJM 352: 2425-2434 [Full Text]  
• Aessopos, A., Farmakis, D., Deftereos, S., Tsironi, M., Tassiopoulos, S., Moyssakis, I., Karagiorga, M. (2005). Thalassemia Heart Disease: A Comparative Evaluation of Thalassemia Major and Thalassemia Intermedia. Chest 127: 1523-1530 [Abstract] [Full Text]  
• Rother, R. P., Bell, L., Hillmen, P., Gladwin, M. T. (2005). The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease. JAMA 293: 1653-1662 [Abstract] [Full Text]  
• Gladwin, M. T., Kato, G. J. (2005). Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia. ASH Education Book 2005: 51-57 [Abstract] [Full Text]  
• Bratton, S. L. (2004). Death, Pulmonary Hypertension, and Sickle Cell Disease. AAP Grand Rounds 11: 63-64 [Full Text]  
• (2004). Pulmonary Hypertension in Sickle Cell Disease. Journal Watch Cardiology 2004: 3-3 [Full Text]